Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension
Abstract Background This was a phase 3, randomized, double-blind, placebo-controlled study. Methods Adult Korean patients with essential hypertension and a baseline mean sitting clinic systolic blood pressure (scSBP) ≥150 and ≤180 mmHg were randomized to 6-week treatment with placebo (n = 65), azils...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
XMLink
2018-02-01
|
| Collection: | Clinical Hypertension |
| Sujets: | |
| Accès en ligne: | http://link.springer.com/article/10.1186/s40885-018-0086-4 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|